XML 84 R69.htm IDEA: XBRL DOCUMENT v3.10.0.1
Acquisitions (Details) - Acquisition of Biscayne Neurotherapeutics, Inc.
$ in Millions
12 Months Ended
Oct. 04, 2018
USD ($)
Dec. 31, 2018
USD ($)
Acquisitions    
Upfront cash payment $ 15  
Maximum combined royalty (as a percent) 12  
Developmental milestones related to intellectual property | Maximum    
Acquisitions    
Contingent consideration based on milestones $ 73  
Sales milestones related to marketing products developed from intellectual property assets | Maximum    
Acquisitions    
Contingent consideration based on milestones $ 95  
Fair value measurement, nonrecurring    
Acquisitions    
Deferred tax asset   $ 1
Fair value measurement, nonrecurring | In-process research and development    
Acquisitions    
Research and development expense   14
Cash paid for in-process research and development asset   $ 15